Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed May 12, 2023
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Common Stock (Right to Buy)
2023-05-10$0.27/sh+30,000$7,968→ 166,000 totalExercise: $0.27From: 2024-05-10Exp: 2033-05-10→ Common Stock (30,000 underlying)